African vaccine production needs a boost. Here’s how Aspen is working to make that happen.

A microfluidic bioprocessing company has set up shop in central Scotland. We spoke to their CEO for an inside view.

We want to hear your thoughts on what mRNA could do for cell and gene therapy

Boston bioscientists have found an unlikely ally in anthrax toxins, which could form the basis for a new kind of painkiller.

Yvonne Duckworth lays out insights into Pharma 4.0 gleaned in a recent report by CRB. VR, AR, AI: is it more than just alphabet soup?

The Russian invasion of Ukraine will disrupt and displace a great deal of work in drug discovery. Here’s why.

A best practice competition developed to encourage labs to pursue more efficient cold storage is now on for 2022.

A technique comparable to the alternative medicinal practice of “cupping” has shown potential in improving delivery of nucleic acid medicines.

A new report has exposed a Humira US price hike that dwarfs the rises in the price of other drugs.

What did our guests have to say during a year of turmoil, change, and hope? Here’s some choice quotes from our 2021 Sitting Down With interviews.